What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Learn which dividend ETFs are inexpensive and still offer reliable income. Compare fee structures and performance to choose cost-conscious options.
20,642 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
A growing share of CFOs now oversee strategic planning, signaling a shift in how companies allocate capital and pursu...
Pony AI reports unit-level profitability in Guangzhou but faces a long road to company-wide profits as it scales flee...
In June, stablecoins moved a record amount on-chain while the broader cash base contracted. The dynamic suggests liqu...
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
In a market eager for AI breakthroughs, one tech stock with eyes stands out as a long-term buy. This article breaks d...
Microsoft Copilot AI signals a bold XRP rally by year-end 2026, driven by real-world catalysts and on-chain activity....
Alphabet outpaced Amazon over the past decade in total returns, turning a $1,000 stake into roughly $7,759 vs Amazon’...
When family turmoil hits, money moves to the foreground. This article uses the idea behind rosie o’donnell says priso...
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...